Exploring the Diverse Biological and Pharmacological Properties of Cyclolinopeptides From Flax: A Comprehensive Study
Authors:
- 6 June 2025
- journal article
- Published by Wiley in ChemistrySelect
- Vol. 10 (22)
Abstract
Cyclolinopeptides (CLs) are active ingredients with significant edible and medicinal value, that have been isolated from Linum usitatissimum L. in recent years. CLs can also be extracted from flaxseed oil, but there is currently no quality control or standardization of their content in flaxseed oil. CLs exhibit elevated efficiency, low toxicity, and a variety of pharmacological activities such as immunomodulation, anti‐osteoporosis, anticancer, antimalarial, and antibacterial effects, among others. Despite the broad application prospects of CLs, the specific mechanism by which they function remains unknown. Although research on CLs is still primarily in the preclinical phase, advancements in separation technology and the increase in flaxseed oil production have significantly reduced extraction costs. This has led to further research into understanding the diverse biological and pharmacological properties of CLs. The aim of this review is to provide a comprehensive overview of recent advancements in understanding the multifaceted biological and pharmacological properties of CLs.Keywords
This publication has 118 references indexed in Scilit:
- The diverse origin of bone-forming osteoblastsJournal of Bone and Mineral Research, 2021
- Cyclosporin A in Membrane Lipids Environment: Implications for Antimalarial Activity of the Drug—The Langmuir Monolayer StudiesThe Journal of Membrane Biology, 2015
- Flaxseed oil reduces the growth of human breast tumors (MCF‐7) at high levels of circulating estrogenMolecular Nutrition & Food Research, 2010
- Synthesis and immunosuppressive activity of new cyclolinopeptide A analogs modified with β‐prolinesJournal of Peptide Science, 2008
- Analogues of cyclolinopeptide a containing α‐hydroxymethyl amino acid residuesPeptide Science, 2004
- Synthesis, conformation, and immunosuppressive activity of CLX and its analoguesBiopolymers, 2003
- Tetrazole analogues of cyclolinopeptide A: Synthesis, conformation, and biologyBiopolymers, 2002
- Caspase-Mediated Calcineurin Activation Contributes to IL-2 Release during T Cell ActivationBiochemical and Biophysical Research Communications, 2001
- Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalystsCellular and Molecular Life Sciences, 1999
- Caspase-3-Like Activity Is Necessary for IL-2 Release in Activated Jurkat T-cellsExperimental Cell Research, 1998